Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Once in nasdaq this can go to 1$
Cancer treatment and tests
Big pharma can use this technology for
Treatment options
Good news we have a great team !!
Not with billions of shares out there it won't.
With such low daily volume and price, probably take less than $50K to accomplish that, neatly…
Sure, needs to double 3 times…
.0025 >> .005 >> .01 >> .02
I tried that once - it hurt my head......
Welcome to OTC reverse split land. Do you guys have any idea the percentage increase just to get back to two cents? Do the math and let us know.
A lot of things were once.......
It was once $1-2!
A dime.
Let's start with a penny...
Would love to see this get back to .10.
What I’m sayin’, bro…
Uncertainty, until there is clarity…
0.0017 or 17/10000. Nice.
But you’re not considering the advantages.
One stinker merges with another. Make it all disappear. By by.
"Impairment". Eye rolls.
>>For the year ended December 31, 2022, the Company reported cash and cash equivalents of $0.8 million, compared with approximately $7.1 million as of December 31, 2021.
Numb skulls here have no clue.
w/o a conversion rate how can u make any kind of decision
Should be an interesting trade today
Kucharchuk did some job with Onc. I can't think of a better person for this job. Eye rolls.
Thank you for explaining….
? For the six months ended March 31, 2023, compensation expense increased by $1,824,706, or 137%, as compared to the six months ended March 31, 2022. The increase was primarily attributable to an increase in stock-based compensation of $1,020,786 related to accretion of stock option expense from the issuance of stock options to employees in August 2022, and an increase in administrative compensation and related employee benefits and expenses resulting from additional employees being hired and a bonus paid to our CFO.
So, is this TANKING the guy who left unloading his shares?
It's deja vu all over again.
Net cash provided by financing activities was $3,340,411 for the six months ended March 31, 2023
cash on hand of $207,922 on March 31, 2023.
On May 5, 2023, the Company appointed Andrew Kucharchuk, a member of the Board of Directors of the Company, as its Chief Financial Officer, effective May 8, 2023. Mr. Kucharchuk was previously the Chief Executive Officer and Chief Financial Officer of OncBioMune Pharmaceuticals, Inc., the Company’s predecessor. The Company and Mr. Kucharchuk agreed that Mr. Kucharchuk’s base salary will be $180,000 per year, and he will be eligible to participate in the benefit plans and programs generally available to the Company’s employees. Mr. Kucharchuk will also be entitled to reimbursement of all reasonable business expenses incurred or paid by him in the performance of his duties and responsibilities for the Company, subject to receipt of evidence of such expenses reasonably satisfactory to the Company.
Termination of Chief Financial Officer
On May 5, 2023, the Company terminated the employment of Thomas Chilcott, effective immediately. Mr. Chilcott previously served as the Company’s Chief Financial Officer, Treasurer and Secretary.
What are they DOING?!?
It needs a lot more than that.
This needs a few buyers with faith and big pockets to buy at 1 cent....
Good news coming..its going to go back tp $$$
Nothing another reverse split won't fix. LOL
Huuuuuuuuuge share structure...
You just watch,soon it will jump like in cents
You dont know this company i think
this news is nothing, this will not do anything for the share price, just watch
this news is nothing, this will not do anything for the share price, just watch
Good news on ther ..some take over news or partership with big pharma
https://www.prnewswire.com/news-releases/theralink-acquires-exclusive-landmark-immunotherapy-patent-including-biomarker-from-vanderbilt-university-301787847.html
It's kind of funny how nobody never-ever says Thank you on these boards. Hmm
Should be asking how much and how these payments correlate to product sold? Or are these just maybe some kind of retainer payment? Still no rev projections provided.
But it really doesn't matter with billions of shares outstanding.
This will run hard any day now. It's load and hold, no brainer.
YAH its 1pm time for a couple of
brewski's
News are better from last 2 months
Got private 4 million dollars
Only 6 billions shares
Someone will take over kn 1$ soon or go back
Followers
|
97
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9827
|
Created
|
01/12/11
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |